title: Flavanone plasma pharmacokinetics from blood orange juice in human subjects.
abstract: Some blood orange juice (BOJ) flavanones may have antioxidant, anti-inflammatory, anti-allergic, hypolipidaemic, vasoprotective and anticarcinogenic properties. The aim of the present study was to evaluate the pharmacokinetics of hesperetin and naringenin in human subjects after BOJ intake. In a cross-over study, seven healthy female volunteers consumed 150 and 300 ml BOJ corresponding to about 51-102 mg hesperetin and to 6-12 mg naringenin, respectively. Plasma samples were collected before, each hour for 8 h and 24 h after BOJ administration and analysed for their content of hesperetin and naringenin by liquid chromatography-MS/MS. The plasma concentrations of these compounds were dose dependent and the peak concentration (Cmax) was reached in 5.1 (sd 0.6) h after BOJ intake. The Cmax of hesperetin was 43.4 (sd 32.4) and 79.8 (sd 60.1) ng/ml after 150 and 300 ml intake, respectively. For naringenin the plasma peak was 16.4 (sd 11.9) and 34.0 (sd 20.6) ng/ml. Moreover, the conjugated forms of these flavanones represent more than 95 % of the plasma concentration. The results indicate that both hesperetin and naringenin are bioavailable after BOJ intake; naringenin seemingly more so than hesperetin.
authors: DiSTAM - Department of Food Science and Microbiology, Division of Human Nutrition, University of Milan Via Celoria 2, Milan, Italy.
authors: Claudio
authors: C
authors: Gardana
authors: Serena
authors: S
authors: Guarnieri
authors: Patrizia
authors: P
authors: Riso
authors: Paolo
authors: P
authors: Simonetti
authors: Marisa
authors: M
authors: Porrini
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000032:analysis / Q000493:pharmacokinetics; D001628:Beverages / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D032084:Citrus sinensis / Q000737:chemistry*; D018592:Cross-Over Studies; D004187:Disaccharides / Q000032:analysis; D004965:Estrogen Antagonists / Q000097:blood / Q000493:pharmacokinetics; D005260:Female; D044950:Flavanones / Q000032:analysis / Q000097:blood / Q000493:pharmacokinetics*; D006569:Hesperidin / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D007408:Intestinal Absorption / Q000502:physiology; D053719:Tandem Mass Spectrometry / Q000379:methods
chemical_list: D000975:Antioxidants; D004187:Disaccharides; D004965:Estrogen Antagonists; D044950:Flavanones; C500601:narirutin; D006569:Hesperidin; C005273:naringenin; C013015:hesperetin